Historicising the “Empty Pipeline”: How Antibiotic Innovation Became a Market Failure (1980–2024)

Wells, N., Alas Portillo, M. Y., Paterson, E. L., Vagneron, F., & Kirchhelle, C. (2025). Historicising the “Empty Pipeline”: How Antibiotic Innovation Became a Market Failure (1980–2024). Public Humanities, 1, e163. https://doi.org/10.1017/pub.2025.10067

(Un)intended Consequences: A Social Sciences Stocktake of a Decade of Global Action Plan-inspired Antimicrobial Governance.

Kirchhelle, C., Alas Portillo, M., Davis, M. D. M., Doron, A., Dreser, A., Fortané, N. F., Haddad, C. … & Chandler, C. I. 

Preprint (under review at Lancet Microbe) (2025) 

http://dx.doi.org/10.2139/ssrn.5272915 

 

Paradoxes of the Antibiotic Pipeline

Alas Portillo, M., Paterson, E. L., Wells, N., Vagneron, F., & Kirchhelle, C. 

Conducted by the DryAP project, in collaboration with the Global Health Centre, Geneva Graduate Institute, Université de Strasbourg (2024)

https://doi.org/10.1057/s41599-024-03211-1 

Witness Seminar: Emerging Financial Models for Antibiotic Development (2000-2016)

Alas Portillo, M., Paterson, E. L., Wells, N., Vagneron, F., & Kirchhelle, C. 

Conducted by the DryAP project, in collaboration with the Global Health Centre, Geneva Graduate Institute, Université de Strasbourg (2024)  

https://doi.org/10.34931/N7PK-3N88

Between superimposition and local initiatives: Making sense of ‘implementation gaps’ as a governance problem of antimicrobial resistance.  

Jeleff, M., Haddad, C., & Kutalek, R. 
SSM-Qualitative Research in Health (2023). 

 

doi.org/10.1016/j.ssmqr.2023.100332